FUNDAMENTALS |
MarketCap: |
3 604.07 mill
|
EPS: |
-4.04
|
P/E: |
-28.80
|
Earnings Date: |
May 02, 2024 |
SharesOutstanding: |
30.98 mill
|
Avg Daily Volume: |
0.448 mill
|
RATING
2024-04-23 |
B-
|
Sell
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Strong Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Buy
|
|
P/E: |
Strong Sell
|
|
Price To Book: |
Strong Buy
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -28.80 | sector: PE -3.05
|
PE RATIO: COMPANY / INDUSTRY |
-0.13x
|
Company: PE -28.80 | industry: PE 222.16
|
DISCOUNTED CASH FLOW VALUE |
$-74.74
(-164.24%)
$-191.08
|
Date: 2024-04-23
|
Expected Trading Range (DAY) |
$ 111.86 - 120.82
( +/- 3.85%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2024-02-28 | Murphy Patrick Michael | Buy | 0 | |
2024-02-27 | Murphy Patrick Michael | Buy | 0 | |
2024-03-04 | Day Mark J. | Sell | 3 248 | Common Stock |
2024-03-04 | Patterson Chad | Sell | 1 077 | Common Stock |
2024-03-04 | Blackford Quentin S. | Sell | 4 221 | Common Stock |
INSIDER POWER |
52.39
|
Last
96 transactions |
Buy:
380 179 | Sell:
104 612 |
Forecast:
16:00 - $116.15
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $116.15
Forecast 2: 16:00 - $116.15
Forecast 3: 16:00 - $116.15
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$116.34 (2.39% )
|
Volume |
0.203 mill
|
Avg. Vol. |
0.448 mill
|
% of Avg. Vol |
45.39 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For IRTC
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date |
Signal |
@ |
Closed |
% |
Feb 8 - 15:34 | buy | $120.75 | N/A | Active |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.